NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1740410968 MD
Verify on CMS → Mehul Vora, MD
Endocrinology, Diabetes & Metabolism Physician in Orland Park, Illinois.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
9K
Medicare Part D claims · 883 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
50%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.0K
119 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mehul Vora, MD filed 8,825 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Orland Park, Illinois, prescribing 50% generic.
- 9K
- Part D claims, 2024
- 50%
- generic prescribing
- $2.0K
- industry payments (Sunshine Act)
- ≥98th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mehul Vora, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1740410968), first enumerated 07/22/2009.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 8,825 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$2.0K in reported industry payments (119 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Illinois statewide board action statistics are published annually — these figures describe aggregate state activity, not Mehul Vora, MD's individual license status. Verify directly with the state medical board.
Source: IDFPR annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1740410968 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1740410968
- ENUM-MID 2009
- TAX-MID 8K Endocrinology, Diabetes
- RX-MID 8,825
- BOOK-THIN 329 in Illinois
- PHOTO-ENUM Raimund Herzog · 2009
Mehul Vora, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
8,825 ≥ 98th percentile 98% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Mehul Vora, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mehul Vora, MD?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
8,825 222% vs specialty avg
Specialty distribution in Illinois
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Illinois providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1740410968 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/22/2009 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mehul Vora, MD. Source: openpaymentsdata.cms.gov.
Total received
$2.0K
Largest payer
AIMMUNE THERAPEUTICS, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Illinois IDFPR 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 - they are NOT specific to Mehul Vora, MD. To verify Mehul Vora, MD's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases
IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Mehul Vora, MD - brand share 42.0%
Endocrinology, Diabetes & Metabolism Physician average
42% brand-name claims vs 50% generic, on 8,825 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
8,825
Total Claims
$3.1M
Total Drug Cost
883
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 21,913.3
- Total Day Supply
- 652,618
- Brand vs Generic
- 42% brand / 50% generic
- Brand Drug Cost
- $2.9M
- Generic Drug Cost
- $103K
- Antibiotic Claims
- 19
Patient Demographics
- Average Patient Age
- 72.4 years
- Avg HCC Risk Score
- 1.51
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 61, 65-74: 500, 75-84: 277, 85+: 45
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mehul Vora, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Levothyroxine Sodium
Levothyroxine Sodium
610 claims
- Metformin Hcl Er
Metformin Hcl Er
581 claims
- Ozempic
Ozempic
461 claims
- Atorvastatin Calcium
Atorvastatin Calcium
413 claims
- Glipizide
Glipizide
391 claims
- Unithroid
Unithroid
356 claims
- Metformin Hcl
Metformin Hcl
353 claims
- Glipizide Er
Glipizide Er
285 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 610 |
| Metformin Hcl Er Metformin Hcl | 581 |
| Ozempic Semaglutide | 461 |
| Atorvastatin Calcium | 413 |
| Glipizide | 391 |
| Unithroid Levothyroxine Sodium | 356 |
| Metformin Hcl | 353 |
| Glipizide Er Glipizide | 285 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 266 |
| Jardiance Empagliflozin | 261 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in IL →
All providers in Illinois →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Mehul Vora, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Mehul Vora, MD's 8,825 claims are above the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Vora, both outside Illinois so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2009)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Illinois
Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as Vora.
One of 329 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Illinois, 5 are shown here.
Maha Abboud
MD FACE
Melrose Park, IL
Dr. Jumana Abdelkarim
MD
Springfield, IL
Dr. Toufic Abdo
MD
Champaign, IL
Dr. Caroline Abe
MD, MPH
Chicago, IL
Dr. Issa Abedmahmoud
MD
Herrin, IL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mehul Vora, MD's specialty? ▼
Mehul Vora, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Orland Park, Illinois. Credentials: MD.
How much does Mehul Vora, MD prescribe under Medicare Part D? ▼
In 2024, Mehul Vora, MD wrote 8,825 Medicare Part D claims totaling $3.1M in drug costs for 883 beneficiaries.
Where is Mehul Vora, MD located? ▼
Mehul Vora, MD is located at 16632 SOUTH 107TH COURT, Orland Park, IL, 60467. Phone: (708) 460-7990.
What is Mehul Vora, MD's NPI number? ▼
Mehul Vora, MD's National Provider Identifier (NPI) is 1740410968, issued on 07/22/2009.
Does Mehul Vora, MD prescribe more brand-name or generic drugs? ▼
Mehul Vora, MD's prescribing is 42% brand-name and 50% generic drugs by claim count, with $2.9M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Mehul Vora, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Mehul Vora, MD's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl Er, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mehul Vora, MD accept Medicare? ▼
Mehul Vora, MD appears in CMS Medicare data with 8,825 Part D claims and 883 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mehul Vora, MD's credentials? ▼
Mehul Vora, MD's NPI is 1740410968 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.